Controlled Substance Management in Chronic Pain
Springer International Publishing (Verlag)
978-3-319-30962-0 (ISBN)
This comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications. Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment. Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource.
Peter S. Staats, MD, MBA, FIPP ABIPPPresident, American Society of Interventional Pain PhysiciansJohns Hopkins UniversityDepartment of Anesthesiology and Critical Care, and Department of OncologyPremier Pain Centers Shrewsbury, NJ Sanford M. Silverman, MD, DABPM, DABAMCEO and Medical Director of Comprehensive Pain Medicine, Pompano Beach, FLDepartment of Anesthesiology, Affiliate Assistant Professor of Clinical Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic UniversityDepartment of Surgery, Boca Raton Regional HospitalDepartment of Surgery, Broward North Medical Center
1 Scope of the pain problem.- 2 Scope of the problem: Intersection of chronic pain and addiction.- 3 Evidence-based treatment for chronic pain with opioids.- 4 Opioid pharmacology.- 5 Pharmacokinetics.- 6 Benzodiazepines, Alcohol and Stimulant Use in Combination with Opioid Use.- 7 Marijuana and cannabinoids for pain.- 8 Adjuvant agents in chronic pain therapy.- 9 Complications of opioid therapy.- 10 Risk mitigation strategies.- 11 Naloxone Treatment of Opioid Overdose.- 12 From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients.- 13 Treating the difficult patient.- 14 Controlled Substance Management: Exit Strategies for the Pain Practitioner.- 15 Alternatives to opiates in the management of non-cancer related pain.- Appendix A: American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain.- Appendix B: Sample Opioid Agreement/Informed Consent.- Appendix C: Opioid Risk Tool.- Appendix D: Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R).- Appendix E: McGill Pain Questionnaire.
"Clinicians who care for patients with chronic pain on a regular basis in their practice are the intended audience. ... It helps to make sense of the chaotic world of opioid therapy for chronic conditions. I cannot think of any other book that comes close to doing justice to this important topic. This is a must read for all pain physicians at all levels of training and experience." (Tariq M. Malik, Doody's Book Reviews, August, 2016)
| Erscheinungsdatum | 08.10.2016 |
|---|---|
| Zusatzinfo | XII, 323 p. 32 illus., 18 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Schmerztherapie | |
| Schlagworte | Adujvant agents • cannabanoids • chronic pain • Controlled Substance Management • DEA • legal aspects • Medicine • Opioid risk • opioids • Pain Medicine • pain problem • Pharmacoeconomics • Pharmacoeconomics and Health Outcomes • Pharmacogenetics • Pharmacokinetics • pharmacology • pharmacotherapy • Practice Management • primary care medicine |
| ISBN-10 | 3-319-30962-5 / 3319309625 |
| ISBN-13 | 978-3-319-30962-0 / 9783319309620 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
